Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$6.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Mar 20 | FDMT | 4D Molecular Therapeutics,… | SSELL | 80 | $8.61 | $689 | -0.2% | Open the original filing on SEC.gov |
| Mar 20 | FDMT | 4D Molecular Therapeutics,… | MEXER | 221 | — | — | +0.5% | Open the original filing on SEC.gov |
| Mar 20 | FDMT | 4D Molecular Therapeutics,… | SSELL | 310 | $8.61 | $2.7K | -0.7% | Open the original filing on SEC.gov |
| Mar 20 | FDMT | 4D Molecular Therapeutics,… | MEXER | 865 | — | — | +1.9% | Open the original filing on SEC.gov |
| Dec 20, 2025 | FDMT | 4D Molecular Therapeutics,… | MEXER◆ | 220 | — | — | — | Open the original filing on SEC.gov |
| Dec 20, 2025 | FDMT | 4D Molecular Therapeutics,… | MEXER◆ | 866 | — | — | — | Open the original filing on SEC.gov |
| Dec 20, 2025 | FDMT | 4D Molecular Therapeutics,… | SSELL | 79 | $8.68 | $686 | -0.2% | Open the original filing on SEC.gov |
| Dec 20, 2025 | FDMT | 4D Molecular Therapeutics,… | MEXER | 220 | — | — | +0.5% | Open the original filing on SEC.gov |
| Dec 20, 2025 | FDMT | 4D Molecular Therapeutics,… | SSELL | 310 | $8.68 | $2.7K | -0.7% | Open the original filing on SEC.gov |
| Dec 20, 2025 | FDMT | 4D Molecular Therapeutics,… | MEXER | 866 | — | — | +1.9% | Open the original filing on SEC.gov |